Published in Drug Week, August 10th, 2007
"Biochemical and morphologic characterization confirm the identification. The isolate reduces selenate and selenite to Se-0 under microaerophilic and denitrifying conditions but not under aerobic conditions. It does not use selenate or selenite as terminal e(-) donors. Se oxyanion reduction causes the formation of Se...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.